%0 Journal Article
%T Stent, drug, polymer—enefits, risks, and opportunities
%A Samuel
%A J.
%A Shubrooks
%J 老年心脏病学杂志(英文版)
%D 2006
%I Science Press
%X It has been well established that use of drug-eluting stents has resulted in marked reduction in neointimal proliferation following stenting and that this is reflected clinically in a very significant decrease in late lumen loss, in-stent restenosis, and target lesion revascularization. This benefit occurs, however, in the setting of delayed endothe-lial and vascular wall healing with its potential for continuing thrombogenicity requiring more prolonged use of dual
%U http://www.alljournals.cn/get_abstract_url.aspx?pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=AD36F34DDC3BA7B0&jid=4DC702B3A2386A4814E2FF9CFB799B27&aid=A845E25CA34E69894B45C75127C4C42F&yid=37904DC365DD7266&vid=38B194292C032A66&iid=0B39A22176CE99FB&sid=4F2F18DD6F870C2C&eid=AA76E167F386B6B3&journal_id=1671-5411&journal_name=Journalofgeriatriccardiology:JGC&referenced_num=0&reference_num=0